Tina,
The inclusion criteria are as follows:
Inclusion Criteria
1. Ongoing androgen deprivation with a testosterone level<50.
2. Evidence of radiographic or PSA progression.
3. Exposure to at least 1, not more than 2, chemotherapy regimens; 1
regimen must include Taxotere.
4. Serum creatinine less than 1.5x ULN.
5. Serum albumin>3.0.
6. Hemoglobin>9.0.
7. ECOG performance status of 2 or less.
8. Histologically confirmed adenocarcinoma without neuroendocrine or
small cell features.
The exclusion criteria are:
1. Abnormal kidney or liver function.
2. Serious non-malignant disease, including uncontrolled congestive
heart failure, hypertension, infection, hepatitis, severe gastrointestinal
disorders, or adrenal dysfunction.
3. Prior ketoconazole exposure.
4. Radiation, chemotherapy, or surgery within 30 days of the first
dose.
you can find more info at: http://www.cancer.gov/clinicaltrials.
Ash
www.cornellroboticprostate.org